Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Rectal Neoplasms 2Neoplasms 2Head and Neck Neoplasms 2Glioma 2Esophageal Neoplasms 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Wilms Tumor 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sinonasal Squamous Cell Carcinoma 1Radiation Injuries 1Prostatic Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Osteosarcoma 1Oropharyngeal Neoplasms 1Melanoma 1Lymphatic Metastasis 1Lung Neoplasms 1Low Anterior Resection Syndrome 1Liposarcoma 1Leiomyosarcoma 1Hepatic Veno-Occlusive Disease 1Glioblastoma 1Germinoma 1Fatigue 1Eyelid Squamous Cell Carcinoma 1

Interventions

X-Rays 6Specimen Handling 6Cyclophosphamide 6Phantoms, Imaging 5Magnetic Resonance Spectroscopy 4fludarabine 3Nuclear Medicine Department, Hospital 3Doxorubicin 3Biopsy 3ulixertinib 2tipifarnib 2selpercatinib 2mifamurtide 2ivosidenib 2fludarabine phosphate 2ensartinib 2cabozantinib 2Methotrexate 2Mesna 2Ifosfamide 2Gemcitabine 2Cisplatin 2trastuzumab deruxtecan 1tazemetostat 1talazoparib 1selinexor 1pembrolizumab 1pazopanib 1palbociclib 1olaparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × Surgical Procedures, Operative × 30 days × Clear all
NCT05691478 2026-05-27

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

National Cancer Institute (NCI)

Phase 2/3 Recruiting
1,122 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡